![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 36, 28276-28284, September 8, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biological Sciences, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan
Received for publication, May 3, 2000, and in revised form, June 26, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Genomic organization of the rat inward rectifier
K+ channel Kir7.1 was determined in an attempt to
clarify how multiple species of its mRNA are generated in a
tissue-specific manner and how its expression is regulated. The rat
Kir7.1 gene spans >40 kilobases (kb) and consists of eight
exons; the first four exons encode the 5'-untranslated region that is
unusually long (~3 kb). The coding region is located in exons 5 and
6. In the testis, exon 4 is processed as four exons (4a-4d), whereas
it is recognized as a single exon in the small intestine. The three
major species of rat Kir7.1 mRNA (1.4, 2.2, and 3.2 kb) were found
to arise from alternative usage of the two promoters and
polyadenylation signals and by alternative splicing of the 5'-noncoding
exons. The splicing pattern of the 5'-noncoding exons is quite complex and highly tissue-specific, suggesting that complex mechanisms may
operate to regulate the Kir7.1 expression. Deletion and mutational analysis of the promoter activity indicated that the rat Kir7.1 gene is
regulated by cAMP through a CCAAT element. The cAMP induction was also
demonstrated using the rat follicular cell line FRTL-5 endogenously
expressing Kir7.1.
Kir7.1 is a member of the inward rectifier K+ channel
(Kir)1 family with two
transmembrane spans and a pore-forming hairpin loop (2TM/1P) (1, 2).
The functional Kir channels are formed by association of four such
2TM/1P subunits and are characterized by their ability to conduct large
inward currents at potentials negative to the K+
equilibrium potential and small outward currents at more positive potentials. The presence of inward rectifier K+ channels
was recognized as early as 1949 (3), and since then the channels have
been characterized mainly by a combination of electrophysiological and
pharmacological techniques. In the past 7 years, however, triggered by
the first molecular cloning of the ATP-regulated inward rectifier ROMK1
(4) and the classical strong rectifier IRK1 (5), a large number of Kir
family members have been cloned, expressed in recombinant systems,
characterized, and classified into seven subfamilies, Kir1-Kir7, based
on their sequence similarities and functional properties such as the
sensitivity to ATP (Kir1 and Kir6) and coupling with G proteins (Kir3).
The above mentioned ROMK1 and IRK1 are now called Kir1.1 and Kir2.1, respectively. In addition to the molecular dissection aimed at clarifying the structure-function relationship, cloning of Kir family
members also helped the determination of their tissue distributions by
Northern blot analysis, in situ hybridization, and
immunohistochemistry, which in turn, together with the
electrophysiological properties, provided useful information concerning
their physiological roles. The functions of the Kir family members
include maintenance of the resting membrane potential, regulation of
the duration of action potential, coupling of cellular metabolism with
membrane excitability, and secretion and absorption of K+
ions across plasma membranes of epithelial cells to maintain K+ homeostasis.
Kir7.1, the latest member of the Kir family, was first described by
Krapivinsky et al. (6) in 1998 by computer-assisted data
base search combined with molecular cloning for full-length cDNA.
Using similar approaches, other groups including ours have also
identified the same channel independently (7-9). Kir7.1 shares the
2TM/1P membrane topology with other members but is unique in exhibiting
very low single channel conductance, which is due to the replacement
with methionine of the positively charged arginine residue in the pore
region that is conserved among other Kir family members (6, 10). Kir7.1
occurs in a wide variety of tissues with high expression being found in
the choroid plexus (8, 9), thyroid gland (9), kidney (6-9, 11), small intestine (6, 7, 9), and testis (6, 8). As for physiological functions,
Kir7.1 has been suggested to help set membrane potential by providing a
steady background K+ current (6) and to be involved in the
transepithelial transport of potassium (8, 9) based, respectively, on
its uniquely low single channel conductance and on its high expression
in ion-transporting epithelial cells. We further suggested its
functional coupling with Na+,K+-ATPase based on
their colocalization, revealed by immunohistochemistry, in the
epithelial cells of the choroid plexus and small intestine and the
follicular cells of the thyroid gland (9).
For better understanding of the physiological roles of Kir7.1, it is
also necessary to know how its levels and activity are regulated to
allow the channel to fulfill the needs of particular tissues and cells.
In the present study, as a first step to address this question, we
isolated the rat Kir7.1 gene, determined its structure and the splicing
patterns of the transcript, and showed that the expression of the
Kir7.1 gene is under the control of cAMP. Interestingly, deletion and
mutational analysis of the promoter region indicated that the cAMP
sensitivity is conferred through an inverted CCAAT element rather than
the CRE or AP-1 sites as recently recognized in the promoters of the
CFTR (12), tryptophan hydroxylase (13), and H ferritin (14, 15) genes.
Another question we addressed here is how multiple species of Kir7.1
mRNA are generated, since three major species of the Kir7.1 message have been demonstrated to occur in the rat in a tissue-specific manner:
2.2-kb species in the testis and 3.2- and 1.4-kb species in other tissues.
cDNA Library Screening--
A rat testis cDNA library
constructed in Genomic Library Screening--
A rat genomic library constructed
in Cloning of the 5'-Flanking Region of the Rat Kir7.1 Gene--
To
isolate the 5'-flanking region of the rat Kir7.1 gene, a rat
GenomeWalking kit (CLONTECH), which is a tagged rat
genomic library, was subjected to nested PCR using Advantage Genomic
Polymerase (CLONTECH). The first round PCR was
performed using a primer for the tagged sequence of the library,
AP1 (5'-GTAATACGACTCACTATAGGGC-3'), rat Kir7.1-specific primer UP-4R
(5'-CCTCTAACCTAGCGATACAGTAGTAAGCG-3', antisense), and the following
conditions: six cycles of 94 °C for 25 s and 72 °C for 4 min
and then 32 cycles of 94 °C for 25 s and 67 °C for 4 min,
with a final elongation of 67 °C for 4 min. The second round PCR was
performed using the primers AP2 (5'-ACTATAGGGCACGCGTGGT-3', for the
tagged sequence nested to AP1) and UP-5R
(5'-TGTCGACCTTCAGAGCTGCATCTTCAGGCG-3', antisense), and the
following conditions: five cycles of 94 °C for 25 s and 72 °C for 4 min and then 22 cycles of 94 °C for 25 s and
67 °C for 4 min, with a final elongation of 67 °C for 4 min. PCR
products were gel-purified, subcloned, and sequenced.
Reverse Transcriptase (RT)-PCR--
RNA was isolated from rat
brain, kidney, small intestine, and testis, and poly(A)+
RNA was purified using an mRNA purification kit (Amersham Pharmacia Biotech). Single strand cDNA was synthesized from 1 µg of
mRNA using SuperScript II reverse transcriptase (Life Technologies, Inc.) and an oligo(dT)12-18 primer. To isolate alternative spliced forms with different 5'-UTR sequences in small intestine, PCR
amplification was performed using the primers S1
(5'-AGGCGTTGGTCCACTTTCCT-3', sense) and A1
(5'-AAGATACACAAGACCTCTTTGAGCAC-3', antisense) and the following
conditions: 94 °C for 3 min and then 30 cycles of 94 °C for 1 min, 60 °C for 1 min, and 72 °C for 2 min, with a final
elongation of 72 °C for 15 min. To determine tissue-specific usage
of 3'-UTR exons, PCR amplification was performed using the primers S4
(5'-CGCCTGCAGTTCCTCTCAGCAATGCAA-3', sense) and A3
(5'-TGAAACTAGAGATACAGACTGT-3', antisense) and the following conditions:
94 °C for 3 min and then 30 cycles of 94 °C for 30 s,
60 °C for 50 s, and 72 °C for 90 s, with a final
elongation of 72 °C for 7 min. PCR products were gel-purified,
subcloned, and sequenced.
3'-Rapid Amplification of cDNA Ends (RACE)--
3'-RACE was
performed using a 5'/3'-RACE kit (Roche Molecular Biochemicals).
cDNA was synthesized from 2 µg of rat small intestine or testis
poly(A)+ RNA using avian myeloblastosis virus reverse
transcriptase and an oligo(dT)-anchor primer
(5'-GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTT(A/C/G)-3'). The cDNA was
amplified using an anchor-specific primer
(5'-GACCACGCGTATCGATGTCGAC-3'), and the sense primer P2
(5'-CGCCTGCAGGTCTCTGCTGTACTCTAT-3') and reamplified with the same
anchor-specific primer and the primer S4. PCR products were
gel-purified, subcloned, and sequenced.
Determination of the Transcription Start Site--
To determine
the transcription start site of the rat Kir7.1 gene, the CapSiteTM
hunting method (16) was used in accordance with the manufacturer's
protocol (Nippon Gene, Tokyo, Japan). CapSite cDNA® from rat small
intestine or testis, in which the 5'-terminal m7GpppN cap
structure of mRNA was removed and recapped by the 3'-end of
a specific 38-mer oligonucleotide (rOligo;
5'-CAACGCAATGTTCCATGCGGTGTCGCATACTACGCATT-3') was subjected to nested
PCR. The first round PCR was performed using the
rOligo-specific primer 1RC
(5'-CAAGGTACGCCACAGCGTATG-3') and rat Kir7.1-specific primer A6
(5'-TCAACTTGGCTGAGGTGACATT-3', for amplification of small intestine
CapSite cDNA), A1 (for small intestine CapSite cDNA), or A4
(5'-TCTCCTCTGTTAGCTGCCAGT-3', for testis CapSite cDNA). The second
round PCR was performed using the rOligo-specific
primer 2RC (5'-GTACGCCACAGCGTATGATGC-3') and rat Kir7.1-specific primer
A7 (5'-ATAATGGCACAGAGGATACAGCAC-3', for small intestine), A8
(5'-CTTTACAATTCCTGCTGTCCAT-3', for small intestine), or A5
(5'-TGTCATGGACAGTGATGATCA-3', for testis). The reactions were
performed using the following conditions: 94 °C for 3 min and then
35 cycles of 94 °C for 30 s, 62 °C for 50 s, and
72 °C for 60 s, with a final elongation of 72 °C for 7 min. PCR products were subcloned and sequenced. The transcription start sites were determined by identification of the boundary sequence between rOligo and rat Kir7.1 mRNA sequence.
DNA Sequencing--
DNA was sequenced by the dideoxynucleotide
chain-termination method using a SequiTherm Long-Read cycle sequencing
kit (Epicentre Technologies, Madison, WI) and an automated laser
fluorescent DNA sequencer (model 4000, LI-COR; Lincoln, NE). DNA
sequences were analyzed using the computer program GENETYX-MAC
(Software Development, Tokyo, Japan). Exon-intron boundaries were
identified by comparing the genomic and cDNA sequences.
Construction of Secreted Alkaline Phosphatase (SEAP)
Reporter Vector--
All DNA fragments of the promoter regions 1 and 2 were amplified by PCR using rat genomic DNA as the template, subcloned
into the pBluescript II SK Analysis of Promoter Activity--
COS-7 (in Dulbecco's
modified Eagle's minimal essential medium containing 10% fetal bovine
serum) and CHO-K1 cells (in Ham's modified F-12 medium containing 5%
fetal bovine serum) were seeded on 35-mm plates to give 70-90%
confluency at the transfection. The appropriate SEAP reporter vector (2 µg) was co-transfected with the pEGFP-C2 vector
(CLONTECH, 1 µg) using LipofectAMINE Plus reagent
(Life Technologies) according to the manufacturer's instructions.
Plasmid DNA (3 µg total) with Plus reagent (12 µl) and
LipofectAMINE reagent (8 µl) were first added to Opti-MEM I (Life
Technologies) in separate tubes to a total volume of 200 µl each. The
solutions were combined and incubated at room temperature for 15 min.
An additional 1.6 ml of Opti-MEM I was added, and the mixture was
applied to one dish of cells, which was then returned to the tissue
culture incubator. After a 3-h incubation at 37 °C, the medium was
replaced with 1 ml of standard culture medium with or without 1 mM 8-Br-cAMP. After 48-h transfection, the medium was
harvested for measurement of SEAP activity, and the cells were lysed
with phosphate-buffered saline for measurement of concentration of
green fluorescent protein. SEAP activity was measured using a Great
EscAPe SEAP fluorescence detection kit (CLONTECH)
according to the manufacturer's instructions. The culture medium
containing SEAP (50 µl) was diluted with an equal volume of 1×
dilution buffer and incubated at 65 °C for 30 min to inactivate the
endogenous alkaline phosphatase activity. The sample was mixed with
assay buffer (194 µl) and incubated at room temperature for 5 min.
Next, the sample was incubated with 1 mM
4-methylumbelliferyl phosphate (6 µl) at room temperature for 1 h, and then the fluorescence was measured at 460 nm when excited at 360 nm using a CytoFluor-4000 plate reader. Concentration of green
fluorescent protein was determined by measuring the green fluorescence
in cell lysates at 530 nm when excited at 480 nm. The SEAP activity was
normalized for transfection efficiency by the green fluorescent protein
concentrations and then averaged from 3-6 independent measurements.
Results are expressed as the means ± S.E. Statistical analysis
was performed using Student's t test.
Cell Culture--
FRTL-5 cells (ATCC CRL 8305; American Type
Culture Collection, Manassas, VA), a strain of rat thyroid follicular
cells, were grown in Coon's modified Ham's F-12 medium supplemented
with 5% (v/v) calf serum and a six-hormone mixture (6H medium)
containing somatostatin (10 ng/ml), hydrocortisone (10 nM),
transferrin (5 µg/ml),
glycyl-L-histidyl-L-lysine acetate (10 ng/ml),
insulin (10 µg/ml), and TSH (1 milliunit/ml). For measuring the
effects of TSH, insulin, and 8-Br-cAMP on the levels of Kir7.1, the
cells were washed twice with Hanks' balanced salt solution and then maintained in culture medium without TSH and insulin (4H medium) for a
period of 4 days before experiments. Under this condition, TSH,
insulin, and 8-Br-cAMP were added to the cells in 4H medium at 1 milliunit/ml, 10 µg/ml, and 1 mM, respectively.
Northern Blot Analysis--
Poly(A)+ RNA was
isolated from the rat stomach, small intestine, and testis, using an
mRNA purification kit. Poly(A)+ RNA (3 µg/lane) was
electrophoresed and transferred to a Magna nylon membrane (Micron
Separations Inc., Westborough, MA) and hybridized with a
32P-labeled rat Kir7.1 cDNA probe. In the case of
determining the effects of TSH and cAMP on the Kir7.1 message levels,
total RNA was isolated from FRTL-5 cells using the method described
previously (9). Total RNA (30 µg/lane) was electrophoresed and
transferred to a Magna nylon membrane and hybridized with
32P-labeled rat Kir7.1,
Na+,K+-ATPase Western Blot Analysis--
FRTL-5 cells were washed six times in
Hanks' balanced salt solution, scraped from culture dishes, and
pelleted by centrifugation at 1000 × g for 10 min.
Pellets were resuspended in 500 µl of lysis buffer (10 mM
sodium phosphate, pH 7.4, 1% (v/v) Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS, 0.15 M NaCl, 2 mM
EDTA, 50 mM NaF, 1 mM benzamidine, 10 mM leupeptin, 1 mM pepstatin, and 1 mM phenylmethanesulfonyl fluoride) and homogenized
immediately. The extract was then centrifuged at 20000 × g for 1 h. The supernatants (10 µg of protein) were
separated by SDS-polyacrylamide gel electrophoresis and electroblotted
to Immobilon-P membrane (Millipore Corp., Bedford, MA). After blocking
in TBST (150 mM NaCl, 0.05% Tween 20, and 10 mM Tris-HCl, pH 8.0) containing 5% nonfat milk for 1 h at room temperature, the blot was incubated with a previously
characterized anti-Kir7.1 peptide antiserum (9) at a 1:1000 dilution
overnight at 4 °C, incubated with alkaline phosphatase-conjugated
goat anti-rabbit IgG (Tago, Burlingame, CA) at a 1:3000 dilution for
4 h at 4 °C, and then developed with 5-bromo-4-chloro-3-indolyl
phosphate and nitro blue tetrazolium chloride (BCIP/NBT) as chromogenic substrates.
Gene Structure--
A rat genomic DNA library, constructed in
The gene consists of eight exons and spans >40 kb (Fig.
1A). The coding region is located in exons 5 and 6. The
exon-intron boundaries (Fig. 2) agree
with the consensus dinucleotide sequences for splice donor (GT-) and
acceptor (-AG) sites except the donor sites following exons 2a (CT-)
and 6 (GC-) and the acceptor sites of introns 4 (-AC) and 7 (-TG).
There are three polyadenylation signals in the 3'-UTR, two of which are
actually used (Figs. 1B and 8A). Rat ID elements,
a class of short interspersed repetitive elements, are present in
introns 2 and 3 (Fig. 1A). As described below, multiple
mRNA species are generated by alternative usage of two
transcription initiation sites and two polyadenylation signals and by
alternative splicing of pre-mRNA.
An interesting duplication of a short segment of the rat Kir7.1 gene
was found within its intron (Fig. 3).
About 800 nucleotides upstream of exon 6, there is a sequence of ~200
nucleotides that is highly identical to that of the intron 5/exon 6 boundary with complete conservation of the splice acceptor site
sequence (Fig. 3, sequence a). If sequence a is used instead
of sequence b during splicing, such a transcript generates a
C-terminally truncated variant form of Kir7.1, since sequence a
contains an in-frame stop codon. However, such a splice variant was not
detected despite our intensive search by RT-PCR using mRNA
preparations from the rat kidney, intestine, and testis.
Transcription Initiation Site and Potential Regulatory
Elements--
The transcription start site of the rat Kir7.1 gene was
determined by CapSite hunting (16), which consists of the following four steps: 1) isolation of poly(A)+ RNA, 2) replacement of
the cap structure (m7Gppp) at the 5' end of mRNA with
an oligoribonucleotide (rOligo), 3) RT-PCR using
primers complementary to rOligo and the cDNA of interest, and 4) nested PCR to increase specificity. The primers used
in the present study are indicated in Figs.
4B and 5B.
Sequencing of the nested PCR products (Figs. 4A and
5A) revealed that there are two transcription start sites:
one defining the 5'-end of exon 1 and the other 105 nucleotides
downstream of the 5'-end of exon 4d. The relationship of exon 4 and
exons 4a-4d will be discussed later.
An approximately 1-kb fragment of the 5'-flanking region (promoter 1)
of the gene was obtained using a rat GenomeWalking kit and sequenced
(Fig. 4C). It contained a TATAA box located at
The promoter 2 region, upstream from the second transcription start
site in exon 4d, was also analyzed and found to contain a TATAA box
( Deletion and Mutational Analysis of Promoters of the Rat Kir7.1
Gene--
To determine whether the putative promoter regions
identified above are functional, we performed reporter gene analysis
using the SEAP reporter system. A series of deletion mutants of
the fragments containing the promoter 1 (
The full-length promoter 2 construct, pP2, exhibited significant levels
of basal activity in both COS-7 and CHO cells, which were
strongly stimulated by cAMP as typically seen in CHO cells (Fig. 6).
When analyzed in CHO cells, deletions from nucleotide Multiple Species of mRNA Generated by Alternative Usage of
Promoters and Polyadenylation Signals and by Alternative Splicing of
Noncoding Exons--
Northern blot analyses indicated that there are
three major transcripts (1.4, 2.2, and 3.2 kb) of the rat Kir7.1 gene
in a tissue-specific manner (Fig. 7 and
Ref. 8). The testis expresses exclusively the 2.2-kb form, and the
other two forms of 1.4 and 3.2 kb are predominantly transcribed in the
small intestine, stomach, kidney (8), lung (8), brain (8), and thyroid
(9). To determine how these transcripts are generated, we performed cDNA cloning, RT-PCR, and 3'-RACE. We first focused on the
testis-specific 2.2-kb transcript and isolated several testis cDNA
clones and found that they all use the first polyadenylation signal
(ATTAAA) present 32 nucleotides downstream from the stop codon TAA in
exon 6 (Figs. 1B and 8). The possibility of using the second
polyadenylation signal in exon 8 was eliminated by RT-PCR (Fig.
8B). Analysis of the cDNA
clones also revealed the presence of two splice variants with similar
sizes: one skipping exons 1b, 4b, 4c, and 5a and the other skipping
exons 4d and 5a (Fig. 1B). Cap site analysis indicated that
only promoter 1 is used in the testis. The calculated length (1.9 kb)
of the testis transcript is shorter than the size (2.2 kb) estimated by
Northern analysis, suggesting the presence of a relatively long poly(A)
tail (1.9 kb + poly(A)
In the small intestine, similar analyses (Figs. 4, 5, 8, and
9) revealed three types of transcripts,
types 1-3, that can be grouped into two categories based on their
sizes: large ones (3.1 and 3.3 kb) corresponding to the 3.2-kb
band of Northern analysis and small ones (1.3 kb) corresponding
to the 1.4-kb band. The large forms are transcribed by the use of the
first promoter located 5' adjacent to exon 1 (Figs. 1B and
9). Although the type 1 transcript of 3.3 kb has a short 3'-UTR, it
contains long exon 4, making it the largest transcript. Type 2 (3.1 kb)
contains relatively long exon 5a and long 3'-UTR. The short form (type
3) is a product of a combination of the second promoter near exon 4d
and the first polyadenylation signal in exon 6 (Figs. 1B, 5,
and 9).
The RNA splicing patterns in the testis and small intestine are
summarized in Fig. 1B. Noteworthy is the splicing concerning exon 4. In the small intestine, exon 4 is either incorporated or
eliminated as a whole, resulting in the 3.3-kb type 1 or 3.1-kb type 2 mRNA (Fig. 1B) that cannot be distinguished by Northern analysis, whereas, in the testis, exon 4 is recognized as four discrete
exons (exons 4a-4d) and three introns (gray boxes). Exon 4 in the small intestinal mRNA is not due to partially spliced pre-mRNA, since RT-PCR amplification of the region yielded
the exon 4 sequence and not the separate 4a-4d sequences. In the
testis, removal of intron 1 occurs in two ways using two splice donor sites and one acceptor site (Fig. 1B). In the small
intestine, the lengths of exons 2 and 5 vary depending on the splicing
using 1) two donor sites and one acceptor site and 2) one donor site and two acceptor sites, respectively (Fig. 1B).
Regulation of Expression of the Kir7.1 Gene by TSH--
Kir7.1 has
previously been demonstrated to be highly expressed in the brain,
thyroid gland, lung, stomach, kidney, small intestine, prostate, and
testis (6-9). Immunohistochemistry (9) and in situ
hybridization histochemistry (8) further established its epithelial
cell localization in the choroid plexus and small intestine and
follicular cell localization in the thyroid gland. We considered that
cell lines derived from these tissues may, if available, be useful for
studying the regulation of expression of the Kir7.1 gene and found that
a rat follicular cell line, FRTL-5, is such a cell line expressing
Kir7.1.
Fig. 10 shows that in FRTL-5 cells, the
expression of Kir7.1 is stimulated by TSH. The addition of TSH to the
culture medium increased the Kir7.1 mRNA levels
time-dependently (t The Kir family belongs to the superfamily of K+
channels, which comprises a diverse family of members classified into
three major structural categories: 1) those possessing the 2TM/1P
membrane topology as typically seen in the Kir family members, 2) those possessing four transmembrane spans and two pore regions (4TM/2P) in a
single subunit, and 3) those possessing six transmembrane spans and a
pore region (6TM/1P) as represented by voltage-gated Kv channels (20,
21). Each category or family has multiple subfamilies that also
comprise multiple members. Despite a large number of cDNA sequences
of K+ channels, information on their gene structures and
transcriptional regulation is limited except the case of
Caenorhabditis elegans, in which nearly 80 genes have been
identified that most likely encode the above mentioned three classes of
K+ channels (22, 23). For example, among the 18 members of
the Kir family so far identified in vertebrates by cDNA cloning (2, 24), only four of them have been characterized in their entire span and
two of them only partially: Kir1.1 (the gene locus is referred to
KCNJ1) (25), Kir2.1 (KCNJ2) (26), Kir3.1
(KCNJ3) (27), Kir3.4 (KCNJ5, partial) (28),
Kir6.1 (KCNJ8) (29), and Kir7.1 (KCNJ13, partial)
(30). In this study, we determined the complete exon-intron
organization, transcription start sites, putative cis-acting
elements, and splicing patterns of the gene for rat Kir7.1 in an effort
to understand the evolutionary relationship among the Kir family
members and regulation of its expression.
The positions and numbers of introns of Kir7.1 are quite different from
those of the other Kir family genes so far characterized, including
Kir1.1 (25), Kir2.1 (26), Kir3.1 (27), Kir3.4 (28), and Kir6.1 (29).
This appears to be consistent with the results of phylogenetic analysis
that indicated early divergence of Kir7.1 from the other members (6).
The 5' region of the rat Kir7.1 gene is surprisingly complex, with 11 5'-noncoding exons (exons 1a, 1b, 2a, 2b, 3, 4a-4d, 5a, and 5b) and
two promoter sites, and hence their expressions are quite complicated,
giving rise to multiple transcripts that have differential tissue
expression (Fig. 1). The total length of the 5'-noncoding exons is
unusually long (3.2 kb). Another interesting unusual finding is that
the 5'-noncoding exon 4 is processed as a single exon in the rat small intestine, whereas it is recognized as four exons (4a-4d) separated by
three introns in the testis. The 3'-UTR is also interrupted by two
introns, and the resulting 3'-noncoding exons 7 and 8 are used in a
tissue-specific manner; exon 8 contains two ATTTA motifs that are
considered to be associated with rapid mRNA turnover. This
complexity may be related to tissue-specific control of message transport, translation, and lifetime.
The rat Kir7.1 gene is known to generate at least three transcripts,
1.4, 2.2, and 3.2 kb, in a tissue-specific manner (8), whereas the
human counterpart yields a single species of 3.2 kb (6, 7, 9). The
present analysis of the rat Kir7.1 gene revealed that the multiplicity
in the message size is mainly due to alternative usage of multiple
promoters and polyadenylation signals and that, quite unexpectedly,
each species is a mixture of mRNA molecules with similar sizes but
with different 5'- and 3'-UTR sequences generated by various
combinations of the noncoding exons by alternative RNA splicing (Fig.
1). Although human Kir7.1 mRNA gives a single band (~3.2 kb) on
Northern blot analysis, the band is likely to represent a number of RNA
species containing, like the rat transcripts, distinct 5'-noncoding
sequences. In fact, the available cDNA sequences for human Kir7.1
are not identical in their 5'-noncoding region and exhibit very
complicated patchwork-like patterns of sequence similarity (accession
numbers: AB013889, AJ007557, AJ006128), suggesting the presence of
multiple 5'-noncoding exons and their alternative splicing. The
presence of two promoters and multiple transcripts with unusually
complex 5'-UTR structures implies that Kir7.1 is one of the key
regulators of K+ homeostasis so that its levels should be
controlled precisely not only transcriptionally but also
posttranscriptionally to meet the demand of specific cells for
K+. The complexity reported here for the structures of the
rat Kir7.1 gene and its transcripts may constitute a useful basis for
future studies on the tissue-specific regulation of expression of the Kir7.1 channel gene.
Although a limited number of the K+ channel family genes
have been characterized, their promoters except that of Kir1.1 (ROMK1) have been shown to lack TATA consensus sequences as often seen in
housekeeping genes. The rat Kir7.1 promoters P1 and P2, however, contain a classical TATA box at positions Sequence analysis of the promoter regions of the rat Kir7.1 gene for
cis-acting elements revealed the presence of CRE and AP-1
sites, which prompted us to ask whether the expression of the Kir7.1
gene can be regulated by cAMP. Reporter gene assays using transient
expression systems demonstrated that both promoters 1 and 2 are
functional and their activities are enhanced by a cAMP analog, but
deletion analysis suggested, contrary to our expectation, that the
elements responsible for the cAMP-mediated regulation of promoters 1 and 2 are the binding site for C/EBP and/or CAAT element and the
inverted CAAT sequence, respectively, rather than CRE and AP-1 sites.
Using the relatively strong promoter, promoter 2, this possibility was
confirmed by mutational analysis, in which the inverted CAAT sequence
is altered by site-directed mutagenesis (Fig. 6, pP2c versus
pP2c-mut). Similar cases of cAMP-mediated induction of
non-CRE-containing promoters have been observed in several genes
including those of CFTR (12), tryptophan hydroxylase (13), and H
ferritin (14, 15). For example, Pittman et al. (12)
demonstrated the requirement of an inverted CCAAT element and
involvement of C/EBP for cAMP-mediated regulation of the CFTR gene. In
the case of the human H ferritin gene, the CAAT-binding factor (NF-Y)
has been shown to form a complex with the co-activator p300/CREB-binding protein on a single CAAT element (15). We next tried
to extend the analysis of cAMP induction to the cells originally
expressing Kir7.1 and observed, by using FRTL-5 (a rat thyroid
follicular cell line), a significant induction of Kir7.1 by cAMP in
both message and protein levels. Cyclic AMP is expected to exert its
stimulatory effects not only at the transcription level but also at the
posttranslational level, since the channel protein contains consensus
phosphorylation sites for cAMP-dependent protein kinase (6,
8, 9). Similar cAMP-dependent regulation of expression and
activity of Kir7.1 may also be operative in other cells expressing
Kir7.1 such as the epithelial cells of the choroid plexus and small
intestine (9). We previously suggested a functional coupling of Kir7.1
and Na+,K+-ATPase based on their abundance and
colocalization in the ion-transporting epithelial cells and the same
polarity of distribution in the apical or basolateral side of plasma
membranes (9). In this context, the fact that the levels of
Na+,K+-ATPase can be regulated by cAMP (17) and
Na+,K+-ATPase has many
cAMP-dependent protein kinase phosphorylation sites (33)
appears to be noteworthy.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
ZAP II (CLONTECH, Palo Alto, CA)
was screened using an EcoRI fragment of rat Kir7.1 cDNA (9). Filters were prehybridized in a solution containing 50%
formamide, 5× SSC, 5× Denhardt's solution, and 0.1% SDS for 1 h at 42 °C and then hybridized overnight at 42 °C in the same solution containing 32P-labeled probe. Filters were washed
twice in 2× SSC and 0.05% SDS at room temperature for 20 min and once
in 1× SSC and 0.1% SDS at 55 °C for 2 h. Positive inserts
were subcloned into pBluescript II SK
(Stratagene, San
Diego, CA) by the in vivo excision and recircularization process in accordance with the manufacturer's protocol and sequenced.
EMBL3 SP6/T7 (CLONTECH) was screened as
described above. Eight positive inserts were digested with
XbaI and NheI or DraI and
StuI, and the digests were subcloned into pBluescript II
SK
using a XbaI or EcoRV
restriction site, respectively, and sequenced.
vector, and verified by
sequencing. The promoter region 1 from nt +76 to
1067 (numbered with
respect to the transcription initiation site) was amplified
using the upstream primer tagged with the XhoI
restriction site (5'-TCCCTCGAGATCTATCATCTCTACAGTCTA-3') and the downstream primer tagged with the HindIII restriction
site (5'-GGCAAGCTTCGTTTAGTTTGTTGTCAAGTG-3'). The amplified
fragment was subcloned into the XhoI and HindIII
sites of the pBluescript II SK
vector (designated pBS-P1)
or pSEAP2-Basic vector (CLONTECH, designated pP1).
The pP1 vector was digested with XhoI and BglII or ApaI, end-filled with Klenow fragments (Takara) and
recircularized to generate plasmids containing segments of the promoter
region from nt +76 to
551 or
315, respectively (designated pP1b or pP1c). The pBS-P1 vector was digested with XhoI and
HpaI, end-filled, and recircularized. And then the segment
of the promoter region from nt +76 to
668 was excised with
KpnI and HindIII and subcloned into the same
sites of the pSEAP2-Basic vector (designated pP1a). The promoter region
2 from nucleotide +64 to
969 (numbered with respect to the
transcription initiation site) was amplified using the upstream primer
tagged with the HindIII restriction site
(5'-TGGAAGCTTTTACTTCAAACAAACAGTGT-3') and the downstream
primer tagged with the EcoRI restriction site (P2R1;
5'-AAGGAATTCGGAAGCTAGCAGACTCTTGTC-3'). The amplified
fragment was subcloned into the HindIII and EcoRI
sites of pSEAP2-Basic vector (designated pP2). The pP2 vector was
digested with HindIII and EcoRV, end-filled, and
recircularized to generate a plasmid containing a segment of the region
from nucleotide +64 to
357 (designated pP2b). The segments of the
region from nucleotide +64 to
551,
188, or
91 were amplified
using the upstream primers tagged with the XhoI restriction
site (5'-TGGCTCGAGCCTTTGCAATTAAGAAAGGGG-3'; P2F3,
5'-TGGCTCGAGGCTTTCTCCAGAGTTGTTAAG-3'; or
5'-TGGCTCGAGCCTGCAGACTAAGTGACCCAAT-3', respectively) and
the downstream primer P2R1. The amplified fragments were subcloned into
the XhoI and EcoRI sites of pSEAP2-Basic vector (designated pP2a, pP2c, and pP2d, respectively). To change nucleotides
96 to
99 (5'-TTGG-3') to 5'-GCTT-3' in the pP2c plasmid,
site-specific mutagenesis was performed as follows. First PCR was
performed using P2F3 and the mutagenic primer
(5'-GTCTGCAGGGGGGAAGCTTAGCTCTGATCA-3'). Second PCR was
performed using the amplified fragment of the first PCR and P2R1, and
the resulting fragment was subcloned into the XhoI and
EcoRI sites of the pSEAP2-Basic vector (designated
pP2c-mut).
1 subunit,
or
-actin cDNA. Hybridization was performed in the solution
containing 50% formamide, 5× SSPE, 2× Denhardt's solution, 0.5%
SDS, and 0.1 mg/ml heat-denatured salmon sperm DNA at 42 °C for
16 h, and the membrane was washed twice in 2× SSC and 0.05% SDS
at room temperature for 20 min and once in 0.1× SSC and 0.1% SDS
overnight at 55 °C. The membranes were exposed to an imaging plate,
and the results were analyzed using a BAS-2000 image analyzer (Fuji
Film, Tokyo, Japan).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
EMBL3, was screened for the Kir7.1 gene using, as a probe, the
previously cloned cDNA (9). Eight positive clones (Fig.
1A) were isolated and sequenced. By comparison of the nucleotide sequences of the genomic clones with the already known cDNA sequence, most of the
exon-intron organization was defined including the exons coding for the
entire open reading frame and 3'-untranslated region (Fig.
1A, exons 5-8). However, the number of exons that encode
the 5'-untranslated region and their positions could not be determined
because of lack of the 5'-UTR sequence information; although our
cDNA clone covered the entire 3'-UTR, it contained only a partial
sequence of the 5'-UTR. To determine the complete 5'-UTR sequence,
therefore, we isolated cDNA clones from a rat testis cDNA
library and sequenced them (Fig. 1B). Furthermore, the
5'-most sequence of cDNA was determined by nested PCR amplification
of cap site cDNA prepared from rat testis and small intestine
mRNA (Figs. 1B, 4, and 5). Again, comparison of the
cDNA and genomic DNA sequences allowed us to determine the complete
exon-intron organization of the rat Kir7.1 gene (Fig. 1A).
The cDNA sequences suggested alternative splicing of Kir7.1
pre-mRNA in the 5'-UTR as described later in detail (Fig.
1B).

View larger version (13K):
[in a new window]
Fig. 1.
Schematic map of the rat Kir7.1 gene and its
transcripts. A, eight genomic DNA clones isolated from
a rat genomic DNA library and exon-intron organization of the rat
Kir7.1 gene. The 5'-flanking region (GW-1) was isolated using a
GenomeWalking kit. Clones containing a part of intron 6 and exon 7 of
12 nucleotides (AAAAAAAAAAAG) were not isolated (broken
line). Introns are indicated by horizontal lines, and
exons are indicated by boxes and numbered 1-8.
The filled and open boxes indicate the coding and
noncoding exon sequences, respectively. In introns 2 and 3, repetitive
DNA elements (ID elements) are present in the reverse
direction. Above the genomic map is shown a partial restriction enzyme
map for XbaI. B, multiple species of rat Kir7.1
transcripts. These structures were deduced from combinations of
cDNA sequence information, which were obtained by cDNA library
screening, RT-PCR, 3'-RACE, and CapSite hunting. In the small
intestine, at least three isoforms are generated by alternative usage
of promoters, alternative splicing, and alternative polyadenylation. In
the testis, at least two forms are generated by alternative splicing in
exons 1 (1a and 1b) and 4 (4a-4d).
Exons 2a and 5a are specific for type 2 transcript. The predicted size
of each isoform is shown at the left. The relatively large
difference between the observed (~2.2 kb) and calculated (1.9 kb)
length of testis transcripts may be due to the presence of a long
poly(A) tail in the case of the testistranscripts.

View larger version (37K):
[in a new window]
Fig. 2.
Exon-intron organization and boundary
sequences of the rat Kir7.1 gene. The sizes of the exons and
introns and nucleotide sequences around the splice sites are indicated.
Exon sequences are in uppercase letters, and
intron sequences are in lowercase letters.
Consensus splice acceptor and donor sequences (34) are shown at the
bottom. N.D., not determined.

View larger version (63K):
[in a new window]
Fig. 3.
Duplication of a short region around the
acceptor site of exon 6. In the intron between exons 5 and 6, there is a short segment (~200 bp, line a and
sequence a) that is very similar to the sequence around the
splice acceptor site of exon 6 (line b and sequence
b). The lower panel compares the sequences. Identical
nucleotides are indicated by asterisks. The amino acid
sequences corresponding to sequences a and b are
shown above and below the nucleotide sequences,
respectively. The splice acceptor site of exon 6 is indicated by a
filled box.

View larger version (32K):
[in a new window]
Fig. 4.
Determination of transcription start site and
sequence analysis of its 5'-flanking region (promoter 1).
A, identification of the cap site by nested PCR. CapSite
hunting method (16) was used to determine the transcription start site
of the rat Kir7.1 gene. CapSite cDNA from rat small intestine or
testis was subjected to nested PCR. The first round PCR was performed
using the rOligo-specific primer 1RC and rat
Kir7.1-specific primer A6 (for amplification of small intestine CapSite
cDNA) or A4 (for amplification of testis CapSite cDNA), whose
positions are shown in B. The second round PCR was performed
using the rOligo-specific primer 2RC and rat
Kir7.1-specific primer A7 (for small intestine, lane 1) or
A5 (for testis, lane 3), whose positions are also shown in
B. For negative control, the second round PCR was performed
using the primer 2RC alone (lanes 2 and 4). The
resulting products were analyzed by 1.3% agarose gel electrophoresis
and visualized by ethidium bromide staining. DNA size marker (in bp) is
shown on the left. B, positions of the primers
used for nested PCR (arrowheads) and products of CapSite
hunting (double-headed arrows). The structure of CapSite
cDNA is shown by a combination of boxes (closed
box representing rOligo sequence that is
artificially introduced as primer sites and open numbered
boxes representing the corresponding 5'-noncoding exons).
C, nucleotide sequence of the promoter region 1. The
transcription start site, determined by sequencing the products of
CapSite hunting, is indicated by an arrow, and the
downstream sequence transcribed as exon 1 is shaded. This
start site is used in both small intestine and testis, but in the case
of small intestine a second start site (Fig. 5) is also used as
schematically summarized in Fig. 1B. A potential TATA box is
located at position
80 relative to the transcription start site. A
putative CCAAT-box and binding sequences for GATA-1, AP-1, Oct-2,
HNF-5, MyoD, C/EBP, and glucocorticoid receptor (GR) are
indicated.
80 and
consensus motifs for several transcription factors, some of which are
shown in Fig. 4C. Between the TATAA box and transcription start site, there is a unique repeat of 26 adenines.
33), which is preceded by a CCAAT box (
75) and a canonical CCAAT
sequence (ATTGG,
100). These locations of the TATAA and CCAAT motifs
strongly suggest that they are functional. Putative binding sites for
transcriptional factors such as AP-1, GATA-1, and CREB/ATF are shown in
Fig. 5C.

View larger version (48K):
[in a new window]
Fig. 5.
Determination of alternative transcription
start site and analysis of its 5'-flanking region (promoter 2).
A, cap site analysis by nested PCR using, as template,
CapSite cDNA from rat small intestine. The first round PCR was
performed using primers 1RC and A1, whose positions are shown in
B. The second round PCR was performed using primers 2RC and
A8 (lane 1). For negative control, the second round PCR was
performed using 2RC alone as primers (lane 2). The resulting
products were analyzed by 1.3% agarose gel electrophoresis and
visualized by ethidium bromide staining. DNA size marker (in bp) is
shown on the left. B, positions of the primers
used (arrowheads) and length of the product of CapSite
hunting (double-headed arrow). C, nucleotide
sequence of the promoter region 2. By sequencing the PCR-amplified
CapSite cDNA, a second start site (arrow) is located in
exon 4d. The potential TATA box is located at position
33 relative to
the transcription start site. The putative CCAAT-box (at
75) and its
canonical form (ATTGG, at
100) and binding sequences for GATA-1,
AP-1, Oct-R, CF-1, and ATF-1 (CRE; cAMP-responsive element) are
indicated. Shaded boxes represent exons 4b, 4c, and
4d.
1067 to +76; numbers refer to the positions relative to the transcription start site) and promoter
2 (
969 to +64) sequences were constructed, inserted into the
pSEAP2-Basic reporter vector, and assayed for the SEAP activity in the
culture medium of transiently transfected COS-7 and CHO-K1 cells. In
the case of promoter 1, no significant basal transcriptional activity
was observed in either COS-7 or CHO cells (Fig.
6). When 8-Br-cAMP was applied to COS-7
cells transfected with the full-length construct pP1 that contains a
CCAAT/enhancer-binding protein (C/EBP) binding site, a CAAT box, and an
AP-1 binding site, there was a marked increase (Fig. 4C).
Deletion constructs lacking the C/EBP binding site and CAAT box showed
no response to 8-Br-cAMP, a membrane-permeable analogue of cAMP,
although they contain the AP-1 binding site (pP1a, Fig. 6).

View larger version (27K):
[in a new window]
Fig. 6.
Promoter activity of the rat Kir7.1 gene in
COS-7 and CHO-K1 cells. Left panel, schematic
representations of DNA constructs containing various lengths of the
promoter regions 1 (A) and 2 (B) of the rat
Kir7.1 gene linked to the SEAP reporter gene. All constructs were
co-transfected with pEGFP-C2 to normalize the transfection efficiency.
Cells were incubated for 48 h in the presence or absence of 1 mM 8-Br-cAMP. Right panel, normalized SEAP
activities of the indicated constructs measured in COS-7 and CHO-K1
cells untreated or treated with 8-Br-cAMP. The activity is expressed as
the value relative to that obtained with promoterless control plasmid,
pSEAP2-Basic, in the absence of 8-Br-cAMP. Open and
closed bars indicate the activities in COS-7 cells untreated
or treated with 8-Br-cAMP, respectively. Shaded and
hatched bars indicate the activities in CHO-K1 cells
untreated or treated with 8-Br-cAMP, respectively. In the mutated
construct (pP2c-mut), the inverted CCAAT sequence (5'-ATTGG-3') was
changed to 5'-AGCTT-3' (the position is indicated by ×). Values are
the means ± S.E. of 3-6 independent experiments. The
asterisk in A indicates a significant difference
between 8-Br-cAMP-treated and nontreated cells (p < 0.05, Student's t test).
969 to
188
(pP2a-c) showed marked increases in the basal and cAMP-stimulated
activities, suggesting the presence of suppressor sequences in the
deleted region (
969 to
189). Further deletion to nucleotide
91
resulted in lowering of the promoter activity to a very low level (Fig.
6, pP2d). As mentioned above, the promoter 2 region contains the
following transcription regulatory elements: a TATAA box (
33), a
CCAAT box (
75), a canonical CCAAT sequence (ATTGG,
100), and a CRE
sequence (ACGTCA,
200). We first considered that the CRE-like
sequence at nucleotide
200 might be the element responsible for the
cAMP sensitivity, but its deletion did not reduce the sensitivity (Fig.
6B; pP2c), leaving us with the canonical CCAAT sequence at
nucleotide
100 as the most likely candidate. Mutation analysis
indicated that this is the case. A mutation in the candidate region,
which changes the sequence ATTGG to AGCTT, decreased the basal and
cAMP-stimulated promoter activity to a level seen with a promoter
deletion to
91 (Fig. 6, pP2c-mut). These results indicate that both
promoters 1 and 2 are highly cell type-specific and dependent on cAMP levels.
2.2 kb).

View larger version (83K):
[in a new window]
Fig. 7.
Multiple forms of rat Kir7.1 mRNA and
their tissue-specific expression. Poly(A)+ RNA (3 µg) from the indicated tissues was analyzed by Northern blotting
using 32P-labeled rat Kir7.1 cDNA spanning the coding
region. Transcripts of three different sizes (about 1.4, 2.2, and 3.2 kb) were detected in a tissue-specific manner. Here, 1.4- and 3.2-kb
transcripts are seen in stomach and small intestine; these two bands
are also present in other tissues of rat including the brain, thyroid,
lung, and kidney as previously demonstrated (8, 9). The testis appears
to express only the 2.2-kb species. The positions of size markers are
indicated to the right.

View larger version (40K):
[in a new window]
Fig. 8.
Tissue-specific 3'-UTR sequences, derived
from exons 6-8, of rat Kir7.1 transcripts. A, sequence
of 3'-UTR of rat Kir7.1 mRNA determined by 3'-RACE. The Kir7.1
transcripts in the rat small intestine were found to be alternatively
polyadenylated by use of either the polyadenylation signal near the end
of exon 6 (dark box) or that of exon 8 (long dark
box). When the proximal polyadenylation signal in exon 6 (ATTAAA)
is used, the addition of a poly(A) tail occurs 24 or 46 nucleotides
downstream (vertical arrowheads); in the case of the distal
polyadenylation site, the signal is tandemly arranged (AATAATAAA) and
followed by a poly(A) tail, 15 nucleotides downstream. In the testis,
however, only the first polyadenylation signal is used. Boundaries of
exons 6 and 7 and exons 7 and 8 are indicated by vertical
lines. The translation termination codon (TAA) is indicated by
stop. Open box indicates an AATAAA sequence that is not used
as a basic polyadenylation signal. Waved lines indicate
adenylate/uridylate-rich element (ATTTA and TTATTTATA) considered to be
involved in message destabilization. Positions of primers for RT-PCR
are marked by arrows. B, detection of the 3'-most exon 8 sequence in the rat Kir7.1 transcripts in the brain, kidney, and small
intestine but not in the testis. One µg of mRNA from the rat
brain, kidney, small intestine, or testis was reverse transcribed with
oligo(dT) primer and subjected to PCR amplification using specific
primers (S4 and A3, indicated in A). The resulting products
were resolved by 1% agarose gel electrophoresis and visualized by
ethidium bromide staining. The transcript containing the exon 8 sequence is represented by a 640-bp product (arrowhead),
which is seen in brain, kidney, and small intestine samples but is not
present in the testis transcripts. DNA size marker (in bp) is shown on
the left.

View larger version (31K):
[in a new window]
Fig. 9.
RT-PCR analysis of alternatively spliced
messages in the rat small intestine. A, positions and
combinations of primers used for RT-PCR amplification of Kir7.1
mRNA. B, analysis of splicing patterns of Kir7.1
transcripts in the rat small intestine by RT-PCR followed by agarose
gel electrophoresis. One µg of mRNA from the rat small intestine
was reverse transcribed with oligo(dT) primer and subjected to PCR
amplification. The resulting products were resolved by 1% agarose gel
electrophoresis and visualized by ethidium bromide staining. A DNA size
marker (in kb) is shown on the left. Two forms (lane
1) were obtained that had different 5'-UTR, type 1 (2198 bp) and
type 2 (984 bp), using primers S1 and A1 that were designed to amplify
the transcripts from the first promoter (promoter 1). Sequencing of the
two bands revealed the splicing patterns of the 5'-noncoding exons as
shown in Fig. 1B. To determine the 3'-UTR structures of
types 1 and 2 transcripts, two primer sets were designed whose
positions are shown in A: 1) S2 and A3 (lane 2)
or A2 (lane 3) and 2) S3 and A3 (lane 4). S2 is
specific for the type 1 transcript containing the exon 4d sequence, and
S3 is specific for type 2 with exon 5a. No DNA band was detected using
S2 and A3 (lane 2), indicating that type 1 uses the proximal
polyadenylation signal and lacks the exon 8 sequence; lane 3 represents positive control. One major band was detected using S3 and
A3 (lane 4), indicating that type 2 contains exon 8. Concerning the transcript from promoter 2 in exon 4d (type 3 transcript), its 5'-UTR structure was established by CapSite hunting
(Fig. 5B), and the short nature of its 3'-UTR was
established by PCR (lanes 2 and
3).
8 h)
(Fig. 10, upper panel). As previously reported by others
(17), similar induction was observed in the
Na+,K+-ATPase mRNA levels (Fig. 10,
middle panel). The stimulatory effect was also confirmed at
the protein level by Western blotting (Fig. 11A). The action of TSH is
known to be mediated through the second messenger cAMP; we therefore
examined the effects of 8-Br-cAMP, a membrane-permeable analog of cAMP.
As expected, it exerted similar stimulatory effects on the Kir7.1
expression (Fig. 11B, lane 5). Insulin, a hormone
known to increase the message levels of the TSH receptor and
thyroglobulin in the thyroid follicular cells (18, 19), also increased
the levels of Kir7.1 in the FRTL-5 cells (Fig. 11B,
lane 3).

View larger version (112K):
[in a new window]
Fig. 10.
Time course of Kir7.1 mRNA induction by
TSH in FRTL-5 cells. Confluent FRTL-5 cells, maintained in 4H
medium for 4 days, were grown in the presence of 1 milliunit/ml TSH for
various time intervals, at which time total RNA was extracted.
Upper panel, Northern blot analysis of Kir7.1 mRNA using 30 µg of total RNA per lane. RNA size markers (in kb) are shown on the
right. Induction by TSH of 3.2- and 1.4-kb transcripts is
evident. Middle panel, Northern blot analysis of the message
levels of Na+,K+-ATPase
1
subunit. As reported by Pressley et al. (17), the levels
were also significantly increased by TSH as clearly seen at 36 and
48 h. Lower panel, Northern blot analysis of
-actin
mRNA performed as a loading control.

View larger version (20K):
[in a new window]
Fig. 11.
Effect of TSH, 8-Br-cAMP, or insulin on
Kir7.1 protein levels in FRTL-5 cells. A, Western blot
analysis of Kir7.1 in FRTL-5 cells treated with TSH for the indicated
time periods. Confluent FRTL-5 cells, maintained in 4H medium for 4 days, were grown in the presence of 1 milliunit/ml TSH for various
times, and total cell homogenates were prepared and subjected to
Western blotting (10 µg of protein/lane). Kir7.1 protein (~54 kDa)
was visualized with anti-Kir7.1 peptide antiserum at a dilution of
1:1000. B, effects of TSH (1 milliunit/ml, lane
2), insulin (10 µg/ml, lane 3), TSH plus insulin (6H,
lane 4), and 8-Br-cAMP (1 mM, lane 5)
on the Kir7.1 protein levels. FRTL-5 cells were treated with various
agents for 48 h and processed for Western blotting as in
A. 4H, basic culture medium for FRTL-5 cells
containing the following four hormones: somatostatin, hydrocortisone,
transferrin, and glycyl-L-histidyl-L-lysine;
6H, 4H plus two additional hormones, TSH and
insulin.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
80 (Fig. 4C) and
33 (Fig. 5C), respectively. Furthermore, promoter 2 contains a CAAT box and a canonical CAAT box in a reasonable context
(at
75 and
100, respectively). This classical nature of the
promoters makes the Kir7.1 gene unique among the family members. The
Kir1.1 gene KCNJ1 also has the TATA and CAAT boxes (25),
and, consistent with this classical nature of the promoter elements,
its expression is highly restricted to the specific segments of the
renal tubules in a splice variant-dependent manner (31,
32).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Hidenari Sakuta for discussion and Setsuko Satoh for secretarial assistance.
| |
FOOTNOTES |
|---|
* This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sport and Culture of Japan, Research Grant for Cardiovascular Diseases 11C-1 from the Ministry of Health and Welfare of Japan, and an SRF grant for biomedical research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequences reported in this paper have been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession numbers AB034241 and AB034242.
To whom correspondence should be addressed. Tel.: 81-45-924-5726;
Fax: 81-45-924-5824; E-mail: shirose@bio.titech.ac.jp.
Published, JBC Papers in Press, June 27, 2000, DOI 10.1074/jbc.M003734200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Kir, inward rectifier potassium channel; 8-Br-cAMP, 8-bromoadenosine 3',5'-cyclic monophosphate; CFTR, cystic fibrosis transmembrane conductance regulator; CRE, cAMP-responsive element; CREB, CRE-binding protein; PCR, polymerase chain reaction; RACE, rapid amplification of cDNA ends; RT-PCR, reverse transcriptase-PCR; SEAP, secreted alkaline phosphatase; TSH, thyroid-stimulating hormone; UTR, untranslated region; bp, base pair(s); kb, kilobase(s) or kilobase pair(s); CHO, Chinese hamster ovary; C/EBP, CCAAT/enhancer-binding protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Doupnik, C. A., Davidson, N., and Lester, H. A. (1995) Curr. Opin. Neurobiol. 5, 268-277 |
| 2. | Reimann, F., and Ashcroft, F. M. (1999) Curr. Opin. Cell Biol. 11, 503-508 |
| 3. | Katz, B. (1949) Arch. Sci. Physiol. 2, 285-299 |
| 4. | Ho, K., Nichols, C. G., Lederer, W. J., Lytton, J., Vassilev, P. M., Kanazirska, M. V., and Hebert, S. C. (1993) Nature 362, 31-38 |
| 5. | Kubo, Y., Baldwin, T. J., Jan, Y. N., and Jan, L. Y. (1993) Nature 362, 127-133 |
| 6. | Krapivinsky, G., Medina, I., Eng, L., Krapivinsky, L., Yang, Y., and Clapham, D. E. (1998) Neuron 20, 995-1005 |
| 7. | Partiseti, M., Collura, V., Agnel, M., Culouscou, J. M., and Graham, D. (1998) FEBS Lett. 434, 171-176 |
| 8. | Döring, F., Derst, C., Wischmeyer, E., Karschin, C., Schneggenburger, R., Daut, J., and Karschin, A. (1998) J. Neurosci. 18, 8625-8636 |
| 9. | Nakamura, N., Suzuki, Y., Sakuta, H., Ookata, K., Kawahara, K., and Hirose, S. (1999) Biochem. J. 342, 329-336 |
| 10. | Wischmeyer, E., Doring, F., and Karschin, A. (2000) FEBS Lett. 466, 115-120 |
| 11. | Ookata, K., Tojo, A., Suzuki, Y., Nakamura, N., Kimura, K., Wilson, C. B., and Hirose, S. (2000) J. Am. Soc. Nephrol., in press |
| 12. | Pittman, N., Shue, G., LeLeiko, N. S., and Walsh, M. J. (1995) J. Biol. Chem. 270, 28848-28857 |
| 13. | Boularand, S., Darmon, M. C., Ravassard, P., and Mallet, J. (1995) J. Biol. Chem. 270, 3757-3764 |
| 14. | Bevilacqua, M. A., Faniello, M. C., Quaresima, B., Tiano, M. T., Giuliano, P., Feliciello, A., Avvedimento, V. E., Cimino, F., and Costanzo, F. (1997) J. Biol. Chem. 272, 20736-20741 |
| 15. | Faniello, M. C., Bevilacqua, M. A., Condorelli, G., de Crombrugghe, B., Maity, S. N., Avvedimento, V. E., Cimino, F., and Costanzo, F. (1999) J. Biol. Chem. 274, 7623-7626 |
| 16. | Maruyama, K., and Sugano, S. (1994) Gene (Amst.) 138, 171-174 |
| 17. | Pressley, T. A., Higham, S. C., Joson, L. A., and Mercer, D. W. (1995) Am. J. Physiol. 268, C1252-C1258 |
| 18. | Santisteban, P., Kohn, L. D., and Di Lauro, R. (1987) J. Biol. Chem. 262, 4048-4052 |
| 19. | Saji, M., Akamizu, T., Sanchez, M., Obici, S., Avvedimento, E., Gottesman, M. E., and Kohn, L. D. (1992) Endocrinology 130, 520-533 |
| 20. | Jan, L. Y., and Jan, Y. N. (1997) Annu. Rev. Neurosci. 20, 91-123 |
| 21. | Kurachi, Y., Jan, L. Y., and Lazdunski, M. (1999) Potassium Ion Channels: Molecular Structure, Function, and Diseases , Academic Press, Inc., San Diego |
| 22. | Wei, A., Jegla, T., and Salkoff, L. (1996) Neuropharmacology 35, 805-829 |
| 23. | Salkoff, L., Kunkel, M. T., Wang, Z. W., Butler, A., Yuan, A., Nonet, M., and Wei, A. (1999) in Potassium Ion Channels: Molecular Structure, Function, and Diseases (Kurachi, Y. , Jan, L. Y. , and Lazdunski, M., eds) , pp. 9-27, Academic Press, Inc., San Diego |
| 24. | Suzuki, Y., Itakura, M., Kashiwagi, M., Nakamura, N., Matsuki, T., Sakuta, H., Naito, N., Takano, K., Fujita, T., and Hirose, S. (1999) J. Biol. Chem. 274, 11376-11382 |
| 25. | Bock, J. H., Shuck, M. E., Benjamin, C. W., Chee, M., Bienkowski, M. J., and Slightom, J. L. (1997) Gene (Amst.) 188, 9-16 |
| 26. | Redell, J. B., and Tempel, B. L. (1998) J. Biol. Chem. 273, 22807-22818 |
| 27. | Schoots, O., Voskoglou, T., and Van Tol, H. H. (1997) Genomics 39, 279-288 |
| 28. | Karschin, C., Dissmann, E., Stuhmer, W., and Karschin, A. (1996) J. Neurosci. 16, 3559-3570 |
| 29. | Erginel-Unaltuna, N., Yang, W. P., and Blanar, M. A. (1998) Gene (Amst.) 211, 71-78 |
| 30. | Derst, C., Doring, F., Preisig, M., Daut, J., Karschin, A., Jeck, N., Weber, S., Engel, H., and Grzeschik, K. H. (1998) Genomics 54, 560-563 |
| 31. | Boim, M. A., Ho, K., Shuck, M. E., Bienkowski, M. J., Block, J. H., Slightom, J. L., Yang, Y., Brenner, B. M., and Hebert, S. C. (1995) Am. J. Physiol. 268, F1132-F1140 |
| 32. | Kawahara, K., and Anzai, N. (1997) Jpn. J. Physiol. 47, 1-10 |
| 33. | Shull, G. E., Greeb, J., and Lingrel, J. B. (1986) Biochemistry 25, 8125-8132 |
| 34. | Breathnach, R., and Chambon, P. (1981) Annu. Rev. Biochem. 50, 349-383 |
This article has been cited by other articles:
![]() |
N. Nakamura, H. Fukuda, A. Kato, and S. Hirose MARCH-II Is a Syntaxin-6-binding Protein Involved in Endosomal Trafficking Mol. Biol. Cell, April 1, 2005; 16(4): 1696 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yang, A. Pan, A. Swaminathan, G. Kumar, and B. A. Hughes Expression and Localization of the Inwardly Rectifying Potassium Channel Kir7.1 in Native Bovine Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3178 - 3185. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||